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Limited susceptibility of three different mouse (Mus musculus) lines  
to Porcine circovirus-2 infection and associated lesions
Tanja Opriessnig, Abby R. Patterson, Douglas E. Jones, Nicole M. Juhan, Xiang-Jin Meng,  
Patrick G. Halbur
A b s t r a c t
Porcine circovirus associated disease (PCVAD), a major global problem for pork producers, is characterized microscopically 
by depletion and histiocytic replacement of follicles in the lymphoid tissues. The objectives of this study were to determine 
1) if Porcine circovirus-2 (PCV-2) inoculated mice (Mus musculus) can develop PCV-2 associated lymphoid lesions and serve 
as a model for PCVAD, and 2) if differences in PCV-2 host susceptibility exist among mice lines. Three groups (n = 48/group) 
of 4-wk-old male mice were used: BALB/c, C57BL/6, and C3H/HeJ. A 2 3 2 factorial analysis was designed for each group 
using PCV-2 inoculation and keyhole limpet hemocyanin in incomplete Freund’s adjuvant injections on day 0 and 7 as factors. 
Necropsies were performed on days 12, 17, 22, 27, 32, and 37. Serum samples collected at each necropsy tested negative for 
anti-IgG PCV-2 antibodies in all mice at all time points by 2 different PCV-2 enzyme-linked immunosorbent assays (ELISA). 
The PCV-2 DNA was detected by polymerase chain reaction (PCR) in 93% (100/108) of tissues and 42.6% (46/108) of serum 
samples from PCV-2-inoculated mice from days 12 to 37. Microscopic lesions consistent with PCV-2 infection were not observed 
in any mice and PCV-2 DNA and PCV-2 antigen were not detected in tissues by in-situ-hybridization or immunohistochemistry 
assays, respectively. Based on incidence of PCV-2 DNA in serum samples, the C57BL/6 mouse line was more resistant to PCV-2 
infection than the other lines. The results indicate the mouse model likely has limited utility to advance understanding of the 
pathogenesis of PCV-2 associated lesions, but mice could potentially be important in the epidemiology of PCV-2.
Résumé
La maladie associée au circovirus porcin (PCVAD) est un problème majeur global pour les producteurs de porcs et est caractérisée en 
microscopie par une déplétion des follicules lymphoïdes et une prolifération histiocytaire dans les tissus lymphoïdes. Les objectifs de la présente 
étude était de déterminer (1) si des souris (Mus musculus) inoculées avec le circovirus porcin de type-2 (PCV-2) développent des lésions 
lymphoïdes associées au PCV-2 et pourraient servir de modèle pour PCVAD, et (2) si des différences de susceptibilité au PCV-2 existent 
entre les lignées de souris. Trois groupes (n = 48/groupe) de souris mâles ont été utilisés : BALB/c, C57/BL/6 et C3H/HeJ. Pour chaque 
groupe, le design expérimental consistait en une analyse factorielle 2 3 2 utilisant comme facteurs l’inoculation de PCV-2 et d’hémocyanine 
de patelle dans de l’adjuvant incomplet de Freund aux jours 0 et 7. Des nécropsies ont été effectuées aux jours 12, 17, 22, 27, 32, et 37. Des 
échantillons de sérum ont été prélevés à chaque nécropsie et se sont avérés négatifs, par deux méthodes immuno-enzymatiques différentes, 
pour la présence d’anticorps anti-IgG PCV-2 chez toutes les souris à tous les moments d’échantillonnage. De l’ADN de PCV-2 a été détecté 
par PCR dans 93 % (100/108) des tissus et 42,6 % (46/108) des échantillons de sérum provenant des souris inoculées avec PCV-2 et prélevés 
entre les jours 12 et 37. Aucune lésion microscopique compatible avec celles observées lors d’infections par PCV-2 n’a pas été vue chez 
aucune des souris, et l’ADN ou l’antigène PCV-2 n’ont pas été détectés dans les tissus, respectivement, par hybridation in situ ou analyses 
immuno-histochimiques. Basé sur l’incidence de l’ADN de PCV-2 dans les échantillons de sérum, la lignée de souris C57/BL/6 était plus 
résistante à l’infection par PCV-2 que les autres lignées. Les résultats indiquent que le modèle murin a une utilité limitée pour aider à la 
compréhension du la pathogénèse des lésions associées au PCV-2, mais que les souris pourraient potentiellement avoir une importance dans 
l’épidémiologie de PCV-2.
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I n t r o d u c t i o n
Porcine circovirus (PCV) is a small, circular single-stranded 
DNA virus of the family Circoviridae (1). Two genera, Circovirus and 
Gyrovirus comprise this family. The genus Gyrovirus has one member, 
Chicken anemia virus, while the genus Circovirus includes Porcine 
circovirus-1 (PCV-1), Porcine circovirus-2 (PCV-2), pigeon circovirus, 
canary circovirus, goose circovirus, duck circovirus, and beak and 
feather disease virus (1). To date, pigs are the only mammalian host 
known to be infected by a member of the Circoviridae family. Several 
studies have reported that mice can become infected and/or harbor 
the virus but no host specific viruses have been identified for mam-
mals other than swine (2–4).
Drawbacks in PCV-2 research include difficulty in finding source 
herds of PCV-2 antibody and virus-free pigs, the low incidence of 
clinical disease and PCV-2 associated lesions when commercially 
available pigs are experimentally infected with PCV-2, and the high 
cost of trials with large numbers of pigs (5). There is also evidence 
of host-related variation in susceptibility to PCV-2 even within the 
same breed and line of pigs (6). Conversely, mice that are PCV-2 
antibody and virus free are readily available, the major mouse 
lines used frequently today (BALB/c, C57BL/6, and C3H/HeJ) are 
inbred strains (less concern of host-related variation), and more 
animals can be included in the trial at minimal expense compared 
with pigs.
Three studies have investigated the susceptibility of mice for 
PCV-2 infection. One study using BALB/c mice found detectable 
PCV-2 nucleic acids in the nuclei and cytoplasm of histiocytes and 
apoptotic cells in germinal centers of lymph follicles as well as in 
hepatocytes in the liver (2). This group also demonstrated mild 
lymphoid depletion and histiocytic infiltration of lymphoid fol-
licles. The mice in this study were infected intraperitoneally as well 
as intranasally with a PCV-2 isolate that had been passaged 4 times 
in cell culture and originated from a case with naturally occurring 
PCVAD. A 2nd study by the same group demonstrated that BALB/c 
mice became infected with PCV-2 resulting in apoptosis in the 
spleen, lymph node, and Peyer’s patches. The authors concluded 
that while mice became infected with PCV-2, the pathogenesis and 
associated lesions were not the same as in the pig model (3). Another 
study inoculated Crl:CD1 (ICR) mice intraperitoneally with the 
4th cell culture passage of a PCV-2-isolate from a case of naturally 
occurring PCVAD (4). Despite the detection of PCV-2 DNA in sera, 
there was no evidence for association of PCV-2 with microscopic 
lesions; however, relevant lymphoid tissues (tonsil, lymph node, 
spleen) that are the major sites of PCV-2 associated lesions in pigs 
were not examined.
In the aforementioned studies, mice were inoculated with PCV-2 
isolates that were not well characterized; therefore, it is unknown 
if these isolates are able to induce the PCV-2 characteristic lesions 
in pigs. The 1st objective of the current study was to determine if 
mice inoculated with a well-characterized, homogenous virus stock 
derived from an infectious PCV-2 clone can induce the hallmark 
lymphoid lesions of PCVAD as we have previously demonstrated 
in the pig model (7–10). The 2nd objective was to determine if there 
are differences in susceptibility to PCV-2 infection among different 
lines of mice.
M a t e r i a l s  a n d  m e t h o d s
Mice and housing
One-hundred-forty-four, 4-week-old, male, specific pathogen 
free mice (BALB/c n = 48, C57BL/6 n = 48, C3H/HeN n = 48) 
were obtained from a commercial source (Harlan Sprague Dawley, 
Indianapolis, Indiana, USA). This source routinely performs sero-
logical assays for multiple agents (a full list of the 22 assays can be 
found at http//:www.harlan.com), bacterial workups for Helicobacter 
spp. as well as for respiratory and enteric organisms, and parasitic 
assays for endo-, ecto-, and enteric parasites. Upon arrival, mice 
were brought to the research facility at Iowa State University and 
randomly assigned to 30 cages containing 3–5 mice in each cage. The 
cages were standard microisolators and contained ground corn cob 
bedding, a self feeder, and an automatic watering device. Bedding, 
water, and feed were routinely autoclaved and the water was acidi-
fied. The diet used was a standard mouse diet (Teklad 7004; Harlan 
Teklad, Madison, Wisconsin, USA). The temperature in the room was 
kept at 22°C and a 12-hour light cycle was implemented. Animal care 
and use protocols for this study were approved by the Iowa State 
University Institutional Animal Care and Use Committee.
Experimental design
On arrival, the 144 mice were inspected, randomly placed into 
cages, and allowed to acclimate for 7 d. The cages were randomly 
assigned to treatment groups by using a computer randomiza-
tion program. Each of these groups of 48 mice were analyzed in a 
2 3 2 factorial study design using PCV-2 inoculation and administra-
tion of keyhole limpet hemocyanin in incomplete Freund’s adjuvant 
(KLH/ICFA) as design factors. A summary of the trial design, includ-
ing the number of mice used in each treatment group, is presented 
in Table I. On day 0, all mice were weighed and, for identification 
purposes, ear clipped. Additionally, a percentage of mice were 
injected with KLH/ICFA (24 of 48 per mouse line) and/or inoculated 
with PCV-2 (36/48 per mouse line; outlined in Table I). On day 7, the 
same mice were re-injected with KLH/ICFA and/or inoculated with 
a 2nd dose of PCV-2. On days 12, 17, 22, 27, 32, and 37 necropsies 
were performed on 8 mice from each group (Table I). At the time of 
necropsy, serum samples were collected for PCV-2 enzyme-linked 
immunosorbent assay (ELISA) and PCV-2 polymerase chain reaction 
(PCR). Additionally, tissue samples were collected for histopathol-
ogy, PCV-2 in-situ hybridization (ISH), and immunhistochemistry 
(IHC). The mice were monitored daily and evaluated for signs of 
respiratory disease or lethargy throughout the trial.
PCV-2 inoculation
A homogenous infectious stock of PCV-2 isolate ISU-40895 (11) 
was generated via direct transfection of PK-15 cells with an infectious 
clone of PCV-2 as previously described by Fenaux et al (7). The infec-
tivity titer was determined by inoculation of PK-15 cells with serially 
diluted virus stock, followed by an immunofluorescence assay (IFA) 
with PCV-2 specific antibodies as described (7). The virus inoculum 
contained infectious PCV-2 at a final titer of 0.5 3 104.25 50% tissue 
culture infective dose (TCID50) per mL. The inoculum was tested 
negative for the presence of porcine parvovirus and PCV-1 nucleic 
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acids by PCR (11,12). Mice were inoculated with 0.05 mL of the 
inoculum intramuscularly. Two intramuscular injections were given 
on each of days 0 and 7, one in the prescapular region and one into 
the epaxial musculature. At each time point, mice were additionally 
dosed with 0.02 mL intranasally. These routes have been shown to 
be successful in pigs. Control mice were similarly sham-inoculated 
with 0.12 mL of sterile saline buffer.
KLH/ICFA administration
In pigs, it has been demonstrated that immune stimulation with 
KLH/ICFA induces increased replication of PCV-2 and increased 
severity of PCV-2 associated lesions (13). In order to assess the effect 
of immune stimulation on the severity of PCV-2 infection in mice, 
administration of KLH/ICFA was included as a design factor: key-
hole limpet hemocyanin (A.G. Scientific, San Diego, California, USA), 
a foreign antigen, was emulsified in incomplete Freund’s adjuvant 
(Sigma-Aldrich, Saint Louis, Missouri, USA). Selected mice (Table I) 
were injected with 0.05 mL KLH/IFA subcutaneously into the tail 
base and with 0.05 mL KLH/IFA subcutaneously into the posterior 
cervical area; the total dose was 50 mg of KLH (14).
Serology
Blood samples were collected at necropsy. The serum samples 
were tested by an indirect IgG PCV-2-ELISA based on the recom-
binant open reading frame 2 capsid protein of PCV-2 (15). Samples 
were considered to be positive if the calculated sample-to-positive 
ratio was $ 0.2. In addition, a commercially available competitive 
IgG PCV-2 ELISA (SERELISA PCV2 AB Mono blocking ELISA IgG; 
Synbiotics, Lyon, France) was used for confirmation of test results 
on all samples.
DNA extraction and PCR
The DNA-extraction on serum samples collected at each necrospy 
day was performed using the QIAamp DNA Mini Kit (Qiagen, 
Valencia, California, USA). The DNA extracts were used for PCV-2 
PCR yielding a 547 base pairs (bp) product as previously described 
(12). In addition, the amount of PCV-2 DNA in serum samples from 
all mice was determined by quantitative real-time PCR (10).
Necropsy
Necropsies were performed on randomly selected mice on days 12, 
17, 22, 27, 32, and 37 (Table I). Gross abnormalities such as lymph 
node enlargement were recorded. Sections of lymph nodes (super-
ficial inguinal, popliteal, axillary, cervical, and mesenteric), thymus, 
ileum, kidney, colon, heart, pancreas, spleen, liver, brain, lung, 
femur, and sternum were collected at necropsy and fixed in 10% 
neutral-buffered formalin and routinely processed for histological 
examination.
Histopathology
Microscopic lesions were evaluated in a blinded fashion by a vet-
erinary pathologist. Lung sections were scored for the presence and 
severity of interstitial pneumonia ranging from 0 to 3 (0 = normal; 
3 = severe). Sections of heart, liver, kidney, ileum, and colon were 
evaluated for the presence of lymphohistiocytic inflammation and 
scored from 0 to 3 (0 = none to 3 = severe).
PCV-2 ISH and IHC
The ISH for detection of PCV-2 specific DNA was performed on 
all formalin-fixed and paraffin-embedded tissue sections by using a 
single-stranded 40-base oligonucleotide probe essentially as previ-
ously described (16). Similarly, IHC was done on all formalin-fixed 
and paraffin-embedded tissues sections using rabbit polyclonal 
anti-PCV-2 serum as described (17).
Statistical analysis
Summary statistics were calculated for all mice within each line to 
assess the overall quality of the data. Analysis of variance (ANOVA) 
was used for cross-sectional assessment of treatment factors. The 
significance level was P , 0.05 followed by pairwise testing using 
the Tukey-Kramer adjustment to identify the groups that were dif-
ferent. Pearson’s chi-squared analysis was used on histopathologic 
data, serum PCR, and tissue PCR data to test if the lesion rate was 
similar between groups.
R e s u l t s
Clinical disease
None of the mice were clinically affected during the study. 
Specifically, no evidence of weight loss, wasting, or respiratory 
disease was noted in any of the mice.
Presence of PCV-2 DNA
All serum samples obtained from the non-inoculated control 
mice were negative for PCV-2 specific nucleic acids as analyzed by 
gel-based and quantitative real-time PCR. In the PCV-2 inoculated 
mice, PCV-2 DNA was detected first on day 12 in pooled tissue 
samples and in serum samples. Pooled tissue samples remained 
positive through day 37 in all groups (Table II). Serum samples were 
also positive through day 37 for the BALB/c mice treatment groups 
(Table III). The C57BL/6 mice had significantly fewer (P = 0.008) 
Table I. Forty-eight mice from each mouse line (BALB/c, 
C57BL/6 and C3H/HeJ) were analyzed in the following 2 3 2 
factorial study design using PCV-2 inoculation and keyhole 
limpet hemocyanin in incomplete Freund’s adjuvant (KLH/ICFA) 
as design factors. For each line, the total number (n) of animals 
per group and the numbers of mice euthanized at each day 
post-inoculation are provided
 Number of mice necropsied  
 on each day post-inoculation
Inoculationa KLH/ICFAb n 12 17 22 27 32 37
— —  6 1 1 1 1 1 1
— Yes  6 1 1 1 1 1 1
PCV-2 — 18 3 3 3 3 3 3
PCV-2 Yes 18 3 3 3 3 3 3
Total number   48 8 8 8 8 8 8
of mice
a Inoculation with PCV-2 was done on days 0 and 7.
b KLH/ICFA administration was done on days 0 and 7.
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mice with positive serum PCR results compared with BALB/c mice. 
No significant differences were noted in the number of PCR positive 
mice between C3H/HeJ and BALB/c mice (P = 0.206) or between 
C3H/HeJ and C57BL/6 mice (P = 0.157). Porcine circovirus-2 DNA 
was present in the tissue of 92.6% (100/108) of the PCV-2 infected 
mice and in serum of 42.6% (46/108) of the PCV-2-infected mice. 
The mean amount of PCV-2 DNA present in serum samples in each 
mouse line on the different necropsy days is summarized in Figure 1. 
The median amount of PCV-2 DNA detected was 10 689 copies per 
1 mL serum (25% quartile 4872 PCV-2 DNA copies; 75% quartile 
23 676 PCV-2 DNA copies). The amount of PCV-2 DNA was not 
significantly (P . 0.05) different between the mouse lines on any 
of the necropsy days. The ISH for PCV-2 was negative in all tissues 
and in all mice.
Presence of anti PCV-2 antibodies
All serum samples obtained from the non-inoculated control mice 
and inoculated mice were negative for anti-IgG PCV-2 antibodies 
as analyzed by indirect and competitive PCV-2 ELISA (data not 
shown).
Macroscopic lesions
No gross lesions were seen in the non-inoculated, non-vaccinated 
control mice. In the non-inoculated, KLH/ICF injected control mice, 
enlarged lymph nodes were noted. In the PCV-2 inoculated mice, 
enlarged lymph nodes were noted. These were most prominent in 
BALB/c mice on days 17 to 27. Non-stimulated PCV-2 inoculated 
mice appeared to have larger lymph nodes than the KLH/ICFA 
stimulated mice.
Microscopic lesions and presence of PCV-2 
antigen
Microscopic lesions consistent with PCV-2 infection (lymphocytic 
depletion and histiocytic replacement of follicles) were not observed 
in any of the mice (control and treatment). A portion of mice in all 
lines and treatment groups had prominent germinal centers in their 
lymphoid tissues (lymph node, thymus, and spleen). No significant 
differences among groups were noted in lesions (prominent germinal 
centers) in the lymph node or thymus. Mice which were treated with 
KLH/ICFA and inoculated with PCV-2, had a significantly greater 
rate of non-reactive follicles (fewer prominent germinal centers were 
seen) in the spleen compared with the following groups: untreated, 
PCV-2 inoculated mice (P = 0.002); untreated, non-inoculated mice 
(P = 0.001); and KLH/ICFA treated, non-inoculated mice (P = 0.002). 
The IHC for PCV-2 was negative on all tissues from all mice.
D i s c u s s i o n
The first objective of this study was to determine if mice infected 
with a well-characterized infectious PCV-2 isolate develop charac-
teristic lesions of PCVAD. While previous studies have indicated 
that BALB/c mice are susceptible to infection with PCV-2, mice had 
been inoculated with low titers of PCV-2 isolates (2,4). Additionally, 
the PCV-2 isolates used in earlier studies had not been tested for 
virulence in an experimental pig model (2,4). The study herein used 
a genetically and pathologically well-characterized PCV-2 clone 
that has been used for several studies in pigs (7,11,18,19). The virus 
derived from the infectious PCV-2 clone has been shown to induce 
PCVAD in conventional pigs (8).
Differences in virulence of PCV-2 isolates have been demonstrated 
in the growing pig model (20,21). It was hypothesized that our well-
characterized PCV-2 isolate would induce more distinct lesions in 
the mice than those observed in previous studies. In contrast, no 
characteristic microscopic lesions characteristic of PCVAD (lymphoid 
depletion and granulomatous lymphadenitis) were identified, and 
ISH and IHC stains were negative. One possible explanation may be 
that the mouse and pig models differ in sites of replication, patho-
genesis, and manifestation of PCV-2 virulence.
Another possible explanation may be that PCV-2 transmission 
occurs by a different route in mice than in pigs. The intramuscular 
and intranasal inoculation routes used herein have been proven to be 
effective in pigs (7,19). In previous studies, the mice were inoculated 
intraperitoneally and intranasally (2,3). The most likely and logical 
explanation for the lack of PCV-2 associated clinical signs and lesions 
is that PCV-2 has limited ability to infect the mouse by 2 intramuscu-
lar and intranasal inoculations. Limited replication would explain the 
low level of viremia seen in this study. Since serum from each mouse 
was only obtained at 1 point in time (on the necropsy day) it is dif-
ficult to evaluate the dynamics of the virus load over time. Based 
on Figure 1, there was a slight increase in amount of PCV-2 DNA 
around day 17 in C3H/HeN and C57BL/6 lines, and the amount of 
PCV-2 appeared to remain on a constant level for the remainder of 
Table II. Incidence of PCV-2 positive tissue pool (liver, lymph 
nodes, lung, spleen) numbers from PCV-2 inoculated mice 
detected by gel-based PCV-2 PCR analysis (number of PCV-2 PCR 
positive tissue pools/total number tissue pools analyzed)
 Day post-inoculation
Line  12 17 22 27 32 37 Total
BALB/c KLH/ICFAa 3/3 2/3 3/3 3/3 3/3 3/3 17/18
 — 3/3 2/3 2/3 1/3 2/3 2/3 12/18
C57BL/6 KLH/ICFAa 3/3 3/3 3/3 3/3 3/3 3/3 18/18
 — 3/3 3/3 3/3 3/3 2/3 3/3 17/18
C3H/HeJ KLH/ICFAa 3/3 2/3 3/3 3/3 3/3 3/3 18/18
 — 3/3 3/3 3/3 2/3 3/3 3/3 18/18
a Keyhole limpet hemocyanin in incomplete Freund’s adjuvant.
Table III. Incidence of PCV-2 positive serum sample numbers 
from PCV-2 inoculated micea as detected by gel-based PCV-2 
PCR analysis (number of PCV-2 PCR positive serum samples/
number of mice sampled)
 Day post-inoculation
Line  12 17 22 27 32 37 Total
BALB/c KLH/ICFAa 3/3 1/3 1/3 2/3 2/3 1/3 10/18
 — 2/3 1/3 2/3 2/3 3/3 2/3 12/18
C57BL/6 KLH/ICFAa 2/3 2/3 0/3 0/3 3/3 0/3  7/18
 — 0/3 0/3 1/3 1/3 0/3 0/3  2/18
C3H/HeJ KLH/ICFAa 1/3 0/3 0/3 3/3 1/3 0/3  5/18
 — 1/3 2/3 1/3 1/3 2/3 3/3 10/18
a Keyhole limpet hemocyanin in incomplete Freund’s adjuvant.
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the experiment. This trend is similar to what is usually seen in pigs 
experimentally inoculated with PCV-2 where the amount of PCV-2 
typically peaks between 14 and 21 days post PCV-2 inoculation, 
decreases slightly thereafter, but remains present over an extended 
period of time (6,8–10).
In addition to the low amount of PCV-2 DNA in serum samples, 
there was also a lack of microscopic PCV-2 associated lesions seen 
in this study. It has been estimated that a minimum of 108 PCV-2 
genomes per 500 ng DNA is required to give visible staining in an 
IHC assay (22). Comparison of the IHC and ISH for the detection 
of PCV-2 found more positive cells with increased signal intensity 
when IHC was used in pigs (23). When the IHC and ISH assays on 
tissues from pigs inoculated with PCV-2 were compared, a similar 
observation was made (unpublished). Therefore, it is likely that 
the replication in the mouse occurs below the analytical sensitivity 
threshold of the IHC and the ISH assays used and the presence of 
PCV-2 DNA in tissue pools may still reflect viremia.
The results of this trial also demonstrated that mice became PCR 
positive on tissue pools and serum samples, but failed to induce 
detectable IgG antibody production. The lack of seroconversion as 
detected by the indirect ELISA was confirmed with a competitive 
ELISA. This test was used as it is not dependent on the binding capa-
bilities of a specific anti-mouse IgG antibody; therefore, a problem 
with antibody binding would likely not account for the apparent 
negative results. The apparent lack of antibody production differs 
from previous studies in which seroconversion of 1/4 mice on day 14 
and 3/4 mice on days 28 and 42 was reported by Kiupel et al (2) 
and seroconversion of 1/5 mice to PCV-1 on day 20 was reported 
by Quintana et al (4).
Differences in the assays used to detect anti-PCV-2 antibodies 
may explain the differences in results. In this trial, ELISA testing was 
used; previous trials determined antibody levels by immunofluores-
cence assay (IFA) (2) or immunoperoxidase monolayer assay (IPMA) 
(4). As both of these assays have subjective endpoints and some 
antigenic cross-reactivity with PCV-1 (24), it is possible that this may 
account for the differences in serology results. Additionally, an inves-
tigation of PCV-2 serological assays performed at various European 
and Canadian laboratories reported that results of PCV-2 IPMA and 
IFA testing varied highly based on the testing protocol (25).
Another objective of this experiment was to determine if there 
are differences in susceptibility to PCV-2 among different lines of 
mice. As no mice displayed gross or microscopic lesions associ-
ated with PCV-2 (even following immune stimulation with KLH/
ICF) this objective could not be evaluated based on these lesions. 
However, a significant difference was noted in the number of mice 
that became PCV-2 positive in serum samples. Previous results 
suggest that BALB/c mice develop a highly polarized T-helper (TH) 
2 response whereas C3H/HeJ mice develop a highly polarized TH1 
response (26). In our study, C57BL/6 mice, whose immune response 
is between BALB/c and C3H/HeJ mice, had a lower incidence of 
PCV-2 viremia in serum samples compared to BALB/c mice. This 
may indicate that both a TH2 and TH1 immune response are required 
to combat PCV-2 infection.
The results of this study indicate that mice may not be a useful 
model to understand immunopathogenesis of PCV-2 associated dis-
ease and lesions. However, mice may be important in the epidemiol-
ogy of PCV-2, as mice apparently replicate PCV-2 and remain viremic 
for extended periods and thus might serve as reservoirs for PCV-2 
and play a role in PCV-2 transmission in pig populations. Further 
research on the susceptibility of mice to PCV-2 on and around pig 
farms is warranted.
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